First monoclonal antibody for dogs with osteoarthritis pain approved by FDA

First monoclonal antibody for dogs with osteoarthritis pain approved by FDA

Today, the U.S. Food and Drug Administration approved Librela (bedinvetmab injection) for the control of pain associated with osteoarthritis (OA) in dogs. Librela is the first monoclonal antibody (mAb) the FDA has approved for use in dogs.

Go to full article: https://www.myvetcandy.com/clinicalupdblog/2023/5/5/first-monoclonal-antibody-for-dogs-with-osteoarthritis-pain-approved-by-fda

Disclaimer: healthcareforpets.com and its team of veterinarians and clinicians do not endorse any products, services, or recommended advice. All advice presented by our veterinarians, clinicians, tools, resources, etc is not meant to replace a regular physical exam and consultation with your primary veterinarian or other clinicians. We always encourage you to seek medical advice from your regular veterinarian.

Recent News

  • Is pain to blame for behavior changes?
  • Jun 23, 2024
  • Cornell surgeons repair pitbull’s perforated small intestine
  • Jun 22, 2024
  • FAU Awarded Grant to Examine Role of Pet Dogs on Military Adolescents
  • Jun 13, 2024
  • Sphynx has lowest life expectancy of domestic cat breeds, research finds
  • Jun 12, 2024